Trial Phase
Trial Status
Paid Participation
Clear All
19 Dementia Trials near Rochester, MN
Power is an online platform that helps thousands of Dementia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
MIBG Scanning for Lewy Body Disease
Rochester, MinnesotaEnhanced Memory Care Environment for Dementia
Rochester, MinnesotaKey Eligibility Criteria
Weighted Blankets for Dementia-Related Agitation
Rochester, MinnesotaNeflamapimod for Lewy Body Dementia
Rochester, MinnesotaFocused Ultrasound Pallidotomy for Parkinson's Disease
Rochester, MinnesotaAL001 for Frontotemporal Dementia
Rochester, MinnesotaBrain Amyloid Imaging for Alzheimer's Disease
Rochester, MinnesotaTau PET Imaging for Frontotemporal Dementia
Rochester, MinnesotaKey Eligibility Criteria
AL001 for Frontotemporal Dementia
Rochester, MinnesotaVerdiperstat for Frontotemporal Dementia
Rochester, MinnesotaKey Eligibility Criteria
Flortaucipir Imaging for Lewy Body Disease
Rochester, MinnesotaECT for Dementia
Rochester, MinnesotaKey Eligibility Criteria
DaTSCAN Imaging for Neurodegenerative Disease
Rochester, MinnesotaAtorvastatin for Preventing Dementia
Rochester, MinnesotaKey Eligibility Criteria
Zoledronic Acid for Parkinson's Disease
Rochester, MinnesotaNeuroinflammation Imaging for Alzheimer's Disease
Rochester, MinnesotaAV-1451 Imaging for Apraxia of Speech
Rochester, MinnesotaKey Eligibility Criteria
Latozinemab Continuation for Neurodegenerative Disease
Rochester, MinnesotaTau PET Imaging for Cognitive Impairment
Rochester, MinnesotaFrequently Asked Questions
How much do Dementia clinical trials in Rochester, MN pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Dementia clinical trials in Rochester, MN work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Dementia trials in Rochester, MN 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Rochester, MN for Dementia is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Rochester, MN several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Dementia medical study in Rochester, MN ?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Dementia clinical trials in Rochester, MN ?
Most recently, we added Latozinemab Continuation for Neurodegenerative Disease, MIBG Scanning for Lewy Body Disease and Neflamapimod for Lewy Body Dementia to the Power online platform.